Effect of in vitroexpanded CD4+CD25+Foxp3+ regulatory T cell therapy combined with lymphodepletion in murine skin allotransplantation

Clinical Immunology

Volumn 135, Issue 1, 2010, Pages 43-54

  Park, Youn Hee ^a   Koo, Sun Kyung ^a   Kim, Youngji ^a   Kim, Hye Mi ^a   Joe, In Yi ^a   Park, Chan Sik ^a   Kim, Song Cheol ^a   Han, Duck Jong ^a   Lim, Dong Gyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

IL 2; Lymphodepletion; Regulatory T lymphocyte; Skin transplantation; Tolerance

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2.43; MONOCLONAL ANTIBODY GK1.5; MONOCLONAL ANTIBODY JES6 1A12; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ FOXP3+ REGULATORY T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; GRAFT REJECTION; GRAFT SURVIVAL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN ALLOGRAFT; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ADOPTIVE TRANSFER; ANIMALS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GRAFT SURVIVAL; HISTOCYTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KAPLAN-MEIERS ESTIMATE; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; SKIN TRANSPLANTATION; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, REGULATORY;

EID: 77649232470     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.11.011     Document Type: Article

References (41)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
2. Bluestone J., and Abbas A. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3 (2003) 253-257
3. - regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168 (2002) 5558-5565
4. Hara M., Kingsley C., Niimi M., Read S., Turvey S., Bushell A., Morris P., Powrie F., and Wood K. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166 (2001) 3789-3796
5. + T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77 (2004) 762-766
6. + T cells in human kidney transplant recipients. J. Am. Soc. Nephrol. 14 (2003) 1643-1651
7. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193 (2001) 1311-1318
8. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
9. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166 (2001) 3008-3018
10. + suppressor T cells in vivo. Nat. Immunol. 3 (2002) 33-41
11. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198 (2003) 235-247
12. + cells: a naturally occurring population of regulatory T cells. Blood 98 (2001) 2736-2744
13. + regulatory T cells. Int. Immunol. 16 (2004) 1189-1201
14. Suchin E., Langmuir P., Palmer E., Sayegh M., Wells A., and Turka L. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166 (2001) 973-981
15. Sanchez-Fueyo A., Weber M., Domenig C., Strom T., and Zheng X. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168 (2002) 2274-2281
16. Wells A., Li X., Li Y., Walsh M., Zheng X., Wu Z., Nunez G., Tang A., Sayegh M., Hancock W., Strom T., and Turka L. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5 (1999) 1303-1307
17. Zheng X., Sanchez-Fueyo A., Sho M., Domenig C., Sayegh M., and Strom T. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19 (2003) 503-514
18. + regulatory T cells promote experimental transplantation tolerance. Blood 109 (2007) 827-835
19. + regulatory T cells. Transplantation 82 (2006) 1749-1755
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
21. Game D., and Lechler R. Pathways of allorecognition: implications for transplantation tolerance. Transpl. Immunol. 10 (2002) 101-108
22. + T cells in mice. Transplantation 85 (2008) 1167-1174
23. + regulatory T cells. Eur. J. Immunol. 38 (2008) 1643-1653
24. Malek T., and Bayer A. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4 (2004) 665-674
25. Boyman O., Kovar M., Rubinstein M., Surh C., and Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311 (2006) 1924-1927
26. Webster K., Walters S., Kohler R., Mrkvan T., Boyman O., Surh C., Grey S., and Sprent J. In vivo expansion of Treg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206 (2009) 751-760
27. Tang Q., and Bluestone J. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212 (2006) 217-237
28. + T-regulatory cell subset has optimal suppressive and proliferative potential. Am. J. Transplant. 4 (2004) 65-78
29. + regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2758-2763
30. + regulatory T cell function in alloimmunity. J. Immunol. 176 (2006) 329-334
31. + regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 212 (2006) 314-329
32. + T regulatory cell development during the neonatal period. J. Exp. Med. 201 (2005) 769-777
33. + regulatory T cell function. J. Exp. Med. 196 (2002) 851-857
34. Neujahr D., Chen C., Huang X., Markmann J., Cobbold S., Waldmann H., Sayegh M., Hancock W., and Turka L. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J. Immunol. 176 (2006) 4632-4639
35. Wu Z., Bensinger S., Zhang J., Chen C., Yuan X., Huang X., Markmann J., Kassaee A., Rosengard B., Hancock W., Sayegh M., and Turka L. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10 (2004) 87-92
36. Yang J., Brook M., Carvalho-Gaspar M., Zhang J., Ramon H., Sayegh M., Wood K., Turka L., and Jones N. Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19954-19959
37. Jones N., Turvey S., Van M.A., Hara M., Kingsley C., Smith C., Mellor A., Morris P., and Wood K. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J. Immunol. 166 (2001) 2824-2830
38. Nash J., Peters M., and Bell P. Comparative survival of pancreatic islets, heart, kidney, and skin allografts in rats, with and without enhancement. Transplantation 24 (1977) 70-73
39. + immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196 (2002) 401-406
40. + T lymphocytes. Blood 103 (2004) 4216-4221
41. + regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am. J. Transplant. 8 (2008) 298-306